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Review of the Anticancer and Cytotoxic 






Euphorbiaceae is a widely spread family. To genus Euphorbia, from that family, belongs 
more than 2000 species. The plants of this genus have been used for a long time in traditional 
medicine. Their main active components: alkanes, triterpenes, phytosterols, tannins, 
polyphenols and flavanoids are supposed to be responsible for different types of activity. 
Euphorbia formosana Hayata is a medicinal plant used to treat rheumatism, liver cirrhosis, 
herpes zoster and it is used as tumor suppressor. Euphorbia tirucalli L. have been used to obtain 
methanolic extracts. Their cytotoxic activity have been examined against many different types 
of cancer cells, such as colon cancer cell line, liver cancer cell line, ovarian cancer cell line 
and prostate cancer cell line. Leukemic cell lines, THP-1 and HL-60, were inhibited after 24 h 
of treatment with 400 μg/mL E. formosana. In vitro anticancer activity assays of E. formosana 
suggest potent anticancer effects that cause both cell cycle arrest and apoptosis of leukemic 
cancer cells. The ethanolic extract of Euphorbia helioscopia L. inhibited the growth of only 
three cancer cell lines, Hep-2 (27%), T-47D (7%) and PC-5 (11%). Cell viability assays were 
conducted on the pancreatic cancer primary tumor cell line to assess the relative toxicity of 
the E. tirucalli extracts. The toxicity of both aqueous and methanolic extracts was found to 
be dose dependent, with cell viability decreasing with increasing extract concentration. Both 
extracts demonstrated similar activity at 50 μg/mL with a viability of 50%, while only the 
methanol extract exerted a significant decrease in cell viability at concentration of 25 μg/mL. 
The pronounced cytotoxic activity of these few species from the genus Euphorbia, suggests 
that it could be very interesting to investigate more deeply about their potent anticancer 
ability. So, the aim of this study was to make a review of the anticancer activity of some of 
the Euphorbia species that were examined experimentally, using different in vitro or in vivo 
assays.
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Introduction 
Natural products, especially medicinal plants, have played a 
significant role in drug discovery and development of therapeutic 
agents. Plants contain many biologically active compounds that 
have potential for development of therapeutic agents. More 
than 35,000 plant species have been used in various regions 
around the world for medical purposes (Al-Faifi et al., 2017). 
The Euphorbiaceae family comprises about 300 genus and 10,000 
species. Euphorbiaceae is among the largest flowering plant 
families consisting of a wide variety of vegetative forms including 
trees, succulents and herbaceous plants. Some of the plants 
from that family are of great importance (Gupta et al., 2013). 
Different species of Euphorbia grow all over the world either wild 
or as cultivated. The genus Euphorbia is the largest genus of the 
medicinal plants widely distributed in China, India, Bangladesh 
and Pakistan (Nyeemet al., 2017). It was reported that plants from 
Euphorbiaceae family are used in folk medicine against venomous 
bites and trichiasis, and as wart removers. Species of Euphorbia are 
characterized by high ecological amplitudes in tropical, subtropical 
and warm temperate regions, and they are widely spread around 
the world. They grow in North Africa and also in the temperate 
parts of Asia, but mainly in the Mediterranean region (Shaaban 
et al., 2018). Several plants of Euphorbiaceae family were tested 
for their anticancer property, but most of them have been used 
in traditional medicine as treatment for various human diseases. 
Antitumor activity against sarcoma and ascites, leukemia in mice 
and cytotoxic activity against certain cancer cell lines were also 
observed (Prakash and Gupta, 2013). Some species have been 
used in treatment of dermatosis, paralysis and pain of human 
body as well as poultice for broken bones ulceration, swelling and 
hemorrhoids. A number of interesting biological activity was also 
reported such as cytotoxic, hepatoprotective, antispasmodic, anti-
inflammatory, antibacterial, antifungal, anti-mutagenic, antiviral, 
pesticide, molluscicidal and larvicidal activities. Interestingly, 
the latex of these plants have shown cocarcinogenic and anti-
carcinogenic activities. 
Euphorbia hirta L. is an annual herb 15-50 cm high, erect or 
ascending, hispid with long often yellowish crisped hairs; stems 
usually terete; leaves often lanceolate or obovate-lanceolate, acute 
or subacute, serrulate or dentate, dark green above, pale beneath, 
base usually unequal sided acute or rounded. It is a common weed 
found throughout the hotter part of India and most of tropical 
and subtropical countries (Lin and Hsieh, 1991). The plants are 
characterized by the presence of milky latex. The extract of E. hirta 
has sedative effect on the mucous membrane of the respiratory and 
genito-urinary tract. The plant has been also used in treatment 
of bowel complications, worm infestations, kidney stones and as 
galactogogues. The whole plant has also been reported to possess 
anti-bacterial, anti-amoebic, anti-fungal, antiviral, spasmolytic, 
anti-diarrheal, sedative, anxiolytic, analgesic, anti-pyretic, anti-
inflammatory, anti-malarial and anti-hypertensive properties 
(Nyeemet et al., 2017). One study also demonstrated that 
hydroalcoholic extract of E. hirta was effective in protecting the 
liver from toxic hepatitis (Brindhaet et al., 2010).
Euphorbia tirucalli L. is probably the best known and most 
widespread of all Euphorbia species. It is a shrub or a small tree 
endemic to tropical areas with pencil-like branches from which it 
derives its vernacular name, the pencil-tree. E. tirucalli is generally 
evergreen since its stems and branches remain green all year 
round and are rarely fed on by herbivores (Lin and Hsieh, 1991). 
It bears white poisonous latex, which may possibly account for the 
low herbivore pressure and medicinal features (Gupta et al., 2013). 
The use of E. tirucalli latex in traditional medicine as a treatment 
for cancer has attracted the recent interest. However, according 
to Munro et al. (2015), whole plant aqueous extracts have shown 
interaction with antioxidant enzyme systems in human leukocytes 
via up-regulation of key antioxidant enzyme genes. This could 
lead to increased cytoxocity, confirming the need for precise 
investigations considering dose and administration of E. tirucalli 
extracts for medicinal purposes (Munro et al., 2015).
Euphorbia formosana Hayata is a Taiwanese native medicinal 
plant. It is an herbaceous branched plant with erected glabrous 
stem. Leaves are sessile, linear-lanceolate, 50-120 mm long and 
5-15 mm wide. They are wide, acute at the apex of the plant and 
attenuate at the base; glabrous on both surfaces. The inflorescence 
of this plant is a cyathium in therminal compound pleiochasia. 
Rhizomes of this species are found as characteristic subterranean 
parts (Lin and Hsieh, 1991). This plant have been used in 
treatment of rheumatism, liver cirrhosis, herpes zoster, scabies 
and photoaging leukemia. Hsieh et al. (2013) tried to explain the 
molecular targets and mechanism of action of E. formosana that 
could be responsible for its apoptotic effect on leukemic cells.
Euphorbia helioscopia L. known as sun spurge is herbaceous 
plant that is widely distributed in Europe, Asia and Northern 
Africa. The stem of E. helioscopia contains a milky liquid that can 
produce a toxic reaction on the skin and mucous membranes. The 
leaves are simple, lobed or unlobed, but not separated in leaflets. 
They are arranged alternate, one leaf per node along the stem. 
Flowers are radically symmetrical and petals or sepals are barely 
present. As a traditional Chinese medicine, E.helioscopia has been 
widely used to treat different disease conditions, such as ascites, 
tuberculosis, dysentery, scabies, lung cancer, cervical carcinoma 
and esophageal cancer. E. helioscopia is featured with slightly toxic 
and wide pharmacological effects. There are no obvious toxic effect 
when patient takes orally its decoction in dose of 150 g/day. Up to 
date, numerous studies revealed that the secondary metabolites 
of E. helioscopia included diterpenoids, flavonoids, triterpenoids, 
polyphenols, steroids and lipids (Cheng et al., 2015). 
Anticancer and cytotoxic activity of species of genus 
Euphorbia
Euphorbia hirta L. 
E. hirta contains flavonoids, terpenoids, phenols, essential oil 
and other compounds (Nyeemet al., 2017). These authors have 
described the rich chemical composition of this plant. In the group 
of flavonoids, E. hirta contains: quercetin, quercitrin, quercitol and 
derivatives, rhamnose, quercetinrhamnoside, a chlorophenolic 
acid, rutin, leucocyanidin, leucocyanidol, myricitrin, cyaniding 
3,5-diglucoside, pelargonidin 3,5-digucoside, camphol, 
hentriacontane, myricyl alcohol, inositol, tetraxerol, friedelin, 
β-sitosterol, ellagic acid and kaempferol. Triterpenoids: 
α-amyrin, β-amyrin, friedelin, teraxerol, taraxerone, 11α, 
12α-oxidoteraxerol, cycloartenol, 24-methylene-cycloartenol 
and euphorbolhexacosonate were also found in this plant (Chi 
et al., 2012). Other isolated terpenoids are sterols, including 
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β-sitosterol, campesterol, cholesterol and stigmasterol. Many 
tannins were present in the extract obtained from this plant: 
dimeric hydrolysable dehydro ellagic tannins, euphorbins A, B, C, 
E and terchebin; the monomeric hydrolysable tannins geraniin, 
2,4,6-tri-o-galloyl-β-D-glucose and 1,2,3,4,6-penta-O-galloyl-β-
D-glucose and the esters 5-O-caffeoyl quinic acid (neo chlorogenic 
acid), 3,4 –di-o-galloyl quinic acid and benzyl gallate. E. hirta 
L. also contains ellagic, gallic, maleic and tartaric acids. Major 
constituents of essential oils include: 3,7,11,15-tetra methyl-2-
hexadecon-1-ol, 6,10,14-trimethyl-2- pentadecanone, hexaecanal, 
phytol and n-hexadecanoic acid (Nyeemet et al., 2017). 
Shao-Ming Chi et al. (2012) isolated a new cylclopentanone 
derivative (1’R,5’R)-5-(5’carboxylmethyl-2’-oxocyclopentyl)-3Z-
pentenyl acetate from E. hirta. Based on spectroscopic analysis 
1D and 2D NMR their structure were elucidated. They have also 
evaluated the cytotoxicity of ethanol extract against K562 (human 
leukemia) and A549 (lung cancer) cell lines. From their results, 
the ethanol extract exhibited a weak activity against A549 cells 
and it was inactive against K562 cells (Shao-Ming Chi et al., 2012). 
Sandeep et al. (2011) studied antitumor activity of E. hirta. They 
used the aerial parts of the plant to obtain ethanol, chloroform 
and petroleum ether extracts. All of the extracts contained tannin, 
saponin, alkaloids and flavonoids. Chloroform and ethanol 
extract enhanced mean survival time and reduced solid tumor 
mass in mice. According to Sandeep et al. (2011) this antitumor 
activity was shown due to presence of flavonoids. Ping et al. (2012) 
investigated the genotoxic effect of methanol extract of E. hirta 
using Allium cepa Assay. The extracts (125, 250, 500 and 1000 μg/
ml) were tested on root meristems of Allium cepa L. Ethylmethane 
sulfonate and distilled water served as positive and negative 
control, respesctively. A decreased mitotic index and increased 
chromosome aberrations were observed as the concentrations 
of E. hirta extract increased. Some abnormalities like stickiness, 
mitosis, bridges and vagrant chromosomes were also observed. 
At interphase stage, micro nucleated cells were also observed. 
This result confirmed that E. hirta methanol extract (1000 μg/ml) 
exerted a significant genotoxic and mitodepressive effect (Ping et 
al., 2012). 
Euphorbia tirucalli L. 
Gupta et al. (2013) discovered the major constituents of latex 
of E. tirucalli. They are isomers of triterpenes, such as euphol, 
tirucallol, cycloeuphordenol, euphorginol, amyrin, lanosterol, 
cycloartenol and others. Munro et al. (2015) showed the anticancer 
properties of tetracyclic triterpene euphol extracted from E. 
tirucalli latex. They found that this compound exhibited dose and 
time dependent cytotoxic effects against a significant number 
of cell lines, with most prominent effects against oesophageal 
squamous cell and pancreatic cell carcinomas. Euphol, the main 
constituent of the sap of E. tirucalli, can be extracted by ethanol. 
It exhibits diverse biological activities, such as anti-viral, anti-
inflammatory and anti-cancer (basal cell carcinomas, leukemia 
and lung, prostate and breast cancers) (Chen et al., 2015). 
Munro et al. (2015) examined the in vitro activity of extracts of 
E. tirucalli on human pancreatic cancer cell line Mia-PaCa2. They 
worked with methanolic and aqueous extracts of E. tirucalli. These 
extracts were obtained from grounded whole plant material (20 
g) extracted by stirring in 400 mL of 80% (v/v) methanol for 17 h 
(for methanolic extract) and 27 min (for aqueous extract) at room 
temperature. Cell viability was determined using the Dojindo Cell 
Counting Kit-8. Different concentrations of E. tirucalli methanolic 
or water extracts (200, 100, 50, 25, 12.5 and 6.25 μg/mL) were used 
in their experiments in order to examine their cytotoxic activity. 
They concluded that toxicity of E. tirucalli methanolic extract was 
dose dependent, and cell viability was decreasing by increasing 
the extract concentration. Both aqueous and methanol extracts 
demonstrated similar activity, and by dose of 50 μg/mL the cells 
resulted in viability of ~50%. The methanol extract exerted a 
significant decrease in cell viability even in a dose of 25 μg/mL 
(Munro et al., 2015).
Euphorbia formosana Hayata
E. formosana have been used in folk medicine for the 
treatment of snakebite as well as dermatosis in Taiwan. E. 
formosana Hayata has rich chemical composition that includes: 
polyphenols (ellagic acid, 3,3’-Di-O-methylellagic acid-4’-
O-bxylopyranoside, 3’-O-methyl-3,4-methylenedioxyellagic 
acid, methyl brevifolincarboxylate, dehydrochebulic acid 
trimethyl ester, gallic acid, brevifolin, octacosylferulate), steroids 
(β-Sitosterol, β-Sitosteryl-3-O-glucoside, β-Sitostenone and 
ergosterol peroxide), peptide (aurantiamide acetate), furan 
(5-hydroxymethylfurfural), coumarins (scopoletin, euoniside 
and 6-methoxy-7,8-methylenedioxycoumarin), diterpenes 
(helioscopinolide E, isopimara-7,15-dien-3-one, epi-manool and 
larixol), triterpenes (euphol, glutinone, cycloart-23-ene-3b,25-
diol and tirucalla-8,25-diene-3,24-diol) and flavonoids (quercetin-
3-O-α-L-rhamnoside and kaempferol-3-O-α-L-rhamnoside) 
(Hsieh et al., 2013). Yu et al. (2012) described the isolation and 
identification of a series of ent-abietane-type diterpenoids 1 – 6 
from E. formosana. These series of ent-abietane-type diterpenoids 
showed cytotoxic, antimicrobial, spasmolytic, antioxidant and 
gastroprotective activities (Yu et al., 2012). Yu et al. (2012) 
prepared extract of E. formosana by extracting from dried aerial 
parts (11.8 kg) three times with methanol (100 L). They concluded 
that ent-abietane-type diterpenoids such as compounds 3–5 
(helioscopinolide A, helioscopinolide B, helioscopinolide C, 
respectively) significantly up-regulated the expressions and 
activation of MMP-2 and -9 (matrix metalloproteinases) in 
human fibrosarcoma cell line HT1080, so they could potentially 
lead to development of novel wound-healing drugs.
Hsieh et al. (2013) used water extract from E. formosana and 
they assessed its anticancer and cytotoxic activity on human lung 
carcinoma cell line A-549, human bladder papillary transitional 
cell carcinoma, cell line BFTC905, human monocytic leukemia-
derived cell line THP-1 and human promyelocytic leukemia cell 
line HL-60. They concluded that both leukemic cell lines, THP-
1 and HL-60, had dose-dependent growth inhibition of 40% and 
30%, respectively, after 24 h of treatment with 400 μg/mL of E. 
formosana water extract (EFW). On the other side, the highest 
EFW concentration of 400 μg/mL did not inhibit growth of 
the lung carcinoma line A-549 and the bladder carcinoma line 
BFTC905. When peripheral blood mononuclear cells (PBMCs) 
were treated with 40 μg/mL EFW over 50% of their growth 
survived. These results showed that EFW selectively inhibited the 
growth of leukemic cancer cells; solid human cancer cells are not 
sensitive to EFW and EFW has low toxicity in normal cells (Hsieh 
et al., 2013).
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Euphorbia helioscopia L. 
E. helioscopia has high content of quercetin, a plant-derived 
flavonoid, but also contains heliosterpenoids A and B. The extracts 
of E. helioscopia L. effectively inhibited the growth of human 
hepatocellular carcinoma lines SMMC-7721, BEL-7402, HepG2, 
gastric carcinoma cell line SGC-7901 and colorectal cancer cell 
line SW-480 (Cheng et al., 2015). According to Mai et al. (2017) 
the terpenoid compounds from E. helioscopia are potent inhibitors 
of P-glycoprotein (ABCB1), and they have also exhibited cytotoxic 
activity against MDA-MB-231 cell lines.
Prakash and Gupta (2013) examined the cytotoxic activity of E. 
helioscopia ethanolic extract (EHE) against different human cancer 
cell lines as well as colon cancer cell line (Colon HT-29, SW-20, 
SiHa), liver cancer cell line (Hep-2), breast cancer cell line (T-47D), 
cervix cancer cell line OVCAR-5 and prostate cancer cell line (PC-
3). These authors concluded that ethanol extract of E. helioscopia 
inhibited the growth of three human cancer cell lines: Hep-2, 
T-47D and PC-5 for 27%, 7% and 11%, respectively. Cheng et al. 
(2015) examined hepatocellular carcinoma growth inhibition by 
E. helioscopia ethyl acetate extract (EAE) in nude mice xenografts. 
They concluded that tumor growth was inhibited and the volume 
significantly decreased after being subjected to EAE treatment. 
These effects were dose dependent (doses from 50 to 200 μg/mL 
EAE). The authors observed a significant downregulation of Cyclin 
D1 protein expression after treatment with EAE, and the staining 
in the cytoplasm was reduced compared with controls. Cell cycle 
data showed that EAE primarily arrested cells in the G1 phase in 
a dose and time dependent manner and reduced the percentage of 
cells in the S phase. Therefore, Cheng et al. (2015) concluded that 
the effect of growth inhibition is mainly mediated by inhibition of 
cell proliferation, which is associated with a profound modulation 
of the expression of cell cycle mediators and the cell cycle 
machinery disruption. In addition, EAE treatment displayed a 
dose dependent inhibitory effect on tumor cell invasion in vitro. 
Wang et al. (2012) evaluated the anticancer effects of E. helioscopia 
extracts on five different human cancer cell lines. In their study 
they showed that EAE significantly inhibited the proliferation of 
SMMC-7721 cells in a time- and dose-dependent manner. EAE 
treatment arrested cell cycle in G1 phase and EAE used at the 
concentration range of 100-200 μg/mL induced a marked increase 
of sub-diploid peak. After EAE treatment at the concentrations of 
150 and 200 μg/mL the percentage of apoptotic cells was increased. 
At the EAE concentration of 200 μg/mL the typical morphology 
of early apoptotic change was observed in SMMC-7721 cells. The 
EAE treatment displayed a dose-dependent inhibitory effect on 
tumor cell invasion and MMP-9 expression. The data showed that 
the flavonoids could be the main constituents of EAE responsible 
for its effects. Based on this data, Wang et al. (2012) concluded 
that EAE of E. helioscopia could have chemopreventive potential 
against the human cancer.
Conclusion
The extracts of Euphorbia are rich in many secondary 
metabolites that possess different biological or pharmacological 
effects. This has been shown through the traditional medicine 
in the recent years. But, the evidence based medicine does not 
gave us many data about its usage. When we speak about the 
anticancer and cytotoxic properties, we have to say that many 
factors should be taken in consideration. From this review it could 
be concluded that its extracts selectively inhibited the growth of 
leukemic cancer cells, while solid human cancer cells are less 
sensitive to EFW, and EFW has low toxicity to normal cells. Up 
to now, Euphorbia extracts have shown cytotoxic activity mainly 
to leukemic cell, fibroblastoma cell line, pancreatic, hepatocelular, 
gastric and colorectal carcinoma cells. The pronounced cytotoxic 
activity of this very few species from the genus Euphorbia suggests 
that it could be very interesting to investigate more deeply their 
potent anticancer ability. According to the results of this study, E. 
hirta showed the weakest cytotoxic activity to the assessed cancer 
cell lines, while other species of Euphorbia have shown strong to 
moderate activity. 
There are different references that emphasize the potential 
use of the extracts obtained from the genus Euphorbia, but these 
studies are not enough to confirm the anticancer and cytotoxic 
properties for all types of cancer. We should stress out that it is 
very important to know which species will be used for extraction 
of the active cytotoxic compounds, which procedures will be used 
in order to obtain the extracts, and main question is selectivity 
to different types of cancer that should be further studied. More 
clinical studies are necessary in order to confirm Euphorbia 
extracts anticancer effect and potential use as chemotherapeutic 
agents. 
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